Bioporto AS THOXF
Trading Information
- Previous Close Price
- $0.29
- Day Range
- $0.15–0.15
- 52-Week Range
- $0.15–0.29
- Bid/Ask
- $0.00 / $0.80
- Shares Outstanding
- 495.10M
- Market Cap
- $73.77M
- Volume/Avg
- 265,500 / 140,500
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 13.16
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 44
- Website
- https://www.bioporto.com
Valuation
|
Metric
|
THOXF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 7.44 |
Price/Sales | 13.16 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
THOXF
|
|---|---|
Quick Ratio | 3.72 |
Current Ratio | 4.09 |
Interest Coverage | — |
Quick Ratio
THOXF
Profitability
|
Metric
|
THOXF
|
|---|---|
Return on Assets (Normalized) | −18.94% |
Return on Equity (Normalized) | −28.55% |
Return on Invested Capital (Normalized) | −26.95% |
Return on Assets
THOXF
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|z^&pHf<% | LOCK|<y | $250B | |||
| Danaher Corp
DHR
| LOCK|FqJy^WxN | LOCK|bx | $156B | |||
| Agilent Technologies Inc
A
| LOCK|?S??ltK | LOCK|%h | $48B | |||
| Illumina Inc
ILMN
| LOCK|>TG@?ZK | LOCK|Nfz> | $44B | |||
| IQVIA Holdings Inc
IQV
| LOCK|r$>x%n | LOCK|P>MB! | $44B | |||
| Waters Corp
WAT
| LOCK|bZ%qQY | LOCK|m@ | $43B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|$?ztM>& | LOCK|RL | $42B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|$%!?dG$^ | LOCK|qKGd | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|Pd$N@yt | LOCK|mp!% | $26B | |||
| Guardant Health Inc
GH
| LOCK|#@^R&^ | LOCK|@% | $25B |
United States